Medow Health AI Raises $3.5M for AI Receptionist Solution

Sydney-based Medow Health AI has successfully closed an additional $3.5 million in Seed funding, bolstering its mission to revolutionize patient communication in specialist medical clinics. This latest infusion of capital, provided by existing backers, brings the company's total Seed financing to $8.5 million, following earlier rounds of $3 million in November and $2 million in January 2025. The company, founded in 2023 by brothers Joel and Josh Freiberg, initially focused on AI-powered medical scribing before pivoting to address a critical administrative bottleneck.

The newly secured funds will accelerate the deployment of Medow's AI Front Desk, a sophisticated system designed to manage inbound patient calls, schedule appointments within existing practice management software, and triage messages to clinical staff. This technology aims to significantly reduce the problem of unanswered calls, which co-founder Joel Freiberg notes can affect up to half of patient inquiries in busy specialist practices due to high demand and staffing pressures. The AI receptionist ensures that every patient interaction is captured and appropriately directed, preventing delays in care and improving patient access to essential services like appointment booking, test result delivery, and prescription refills.

This strategic expansion into a multi-product platform signifies a major evolution for Medow Health AI. "This is a pivotal shift in our business as we’re moving to a multi-product platform and servicing the entire clinic, not just the doctors," stated Joel Freiberg. The AI Front Desk is already gaining significant traction, with over 1,000 specialist clinics across Australia and New Zealand adopting the solution. The company projects it will facilitate approximately three million specialist consultations through its platform in 2026, underscoring its rapid market penetration and the growing demand for AI-driven administrative efficiencies in healthcare.

The funding round saw continued support from key industry figures, including Professor Michael Boyer, CEO of Chris O’Brien Lifehouse, and renowned orthopaedic surgeon Dr Michael Solomon. Their sustained investment highlights confidence in Medow's vision and its potential to address pressing challenges within the healthcare sector. The broader medtech market is experiencing robust growth, with AI solutions increasingly being adopted to enhance operational efficiency and patient outcomes. The global AI in healthcare market is projected to reach substantial figures in the coming years, driven by advancements in machine learning and the need for scalable healthcare solutions.

Medow Health AI's innovative approach addresses a tangible pain point for specialist clinics, where administrative tasks often detract from core clinical duties. By automating and optimizing the front-desk functions, the company empowers medical professionals to focus more on patient care. The AI Front Desk's ability to integrate seamlessly with existing systems and intelligently route communications represents a significant step forward in streamlining clinic operations. This development is particularly relevant in a market where patient experience and efficient service delivery are becoming key differentiators.

The company's trajectory, from an AI scribe to a comprehensive clinic management tool, demonstrates a keen understanding of market needs and a capacity for agile product development. With this latest funding, Medow Health AI is well-positioned to expand its reach and further solidify its role as a leader in AI-driven healthcare administration. The success of this Seed round, especially with repeat investors, signals strong market validation for their technology and business model.